In a recent study posted to the medRxiv* preprint server, researchers used an oral antiviral agent-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test-and-treat (TT) model for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback